SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-18
👔
LIGAND PHARMACEUTICALS INC
@LGND_InsiderForm 4 Filing: Sabba Stephen L Sells $686,678.85 of $LGND
INSIDER SALE
⚡ MATERIALITY: 5/10
corporate issuer
LIGAND PHARMACEUTICALS INC
Ticker: $LGND
Transaction Value
$686,678.85
Price/Share: $160.06
transaction date
2026-06-16
Shares: 4,290
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Sabba Stephen L, holds the title of Director at LIGAND PHARMACEUTICALS INC.
On 2026-06-16, the insider transacted 4,290 shares.The shares were transacted at a weighted average price of $160.06 per share, resulting in a total market-relevant value of $686,678.85.
Executive Summary Summary
Sabba Stephen L (Director) sold $687K of $LGND
Post-Transaction Position: 33,629 shares
SEC Accession No: 0001104659-26-075456 (CIK: 1442372)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.